The Notch pathway is an extensively utilized, evolutionarily maintained regulatory system which mediates a wide range of fate decisions among multipotent precursor cells by inhibiting differentiation along one pathway while promoting self-renewal or differentiation along an alternative pathway. Notch signaling has been shown to affect haematopoietic stem cell (HSC) self-renewal and differentiation, T cell versus B cell fate specification, and myeloid cell differentiation. The diverse functions of Notch in vertebrates are facilitated by complex in-teractions between four Notch receptors and five Notch ligands, all of which are expressed by hematopoietic cells and stromal cells. More-over, Notch signaling is modulated by genes such as fringe as well as two unusual types of O-linked glycosylation; the addition of O-linked glucose (O-glucose) and O-linked fucose (O-fucose). Our goal is to determine whether in vitro myeloid differentiation is regulated by Notch activation, and whether this is a fucose-dependent process. Specifically, we focused our research on common myeloid progenitor (CMP) cell differentiation and the dynamic change of Notch-targeted genes during Notch regulated myeloid differentiation that is modified by fucosylation.
No takes yet. Share an insight, caveat, or question.
Charles A. Su (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: